Destiny Wealth Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.2K Buy
+110
New +$36.2K ﹤0.01% 530
2023
Q1
Sell
-51
Closed -$26.2K 312
2022
Q4
$26.2K Sell
51
-93
-65% -$47.2K 0.01% 366
2022
Q3
$65K Hold
144
0.01% 255
2022
Q2
$69K Buy
144
+75
+109% +$37.1K 0.02% 255
2022
Q1
$34K Hold
69
0.01% 350
2021
Q4
$32K Hold
69
0.01% 363
2021
Q3
$26K Buy
+69
New +$26.2K 0.01% 355
2021
Q2
Sell
-69
Closed -$25K 274
2021
Q1
$25K Sell
69
-61
-47% -$19.6K 0.01% 341
2020
Q4
$42K Buy
+130
New +$39.9K 0.01% 301

Other funds holding ELV

Destiny Wealth Partners's ELV Position: Q1 2026 in Review

Destiny Wealth Partners opened a new position in Elevance Health (ELV) in Q1 2026: 110 shares worth $32.2K. The stake represents ﹤0.01% of the portfolio and ranks #530 among its holdings. This is a return to the name: Destiny Wealth Partners previously reported a position in ELV as recently as Q4 2022.

Destiny Wealth Partners first reported a position in ELV in Q4 2020 and has held it in 9 quarters since. The position peaked at $69K in Q2 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Destiny Wealth Partners held 110 shares of Elevance Health worth $32.2K as of Q1 2026.
  • Elevance Health was a new Destiny Wealth Partners position in Q1 2026.
  • Elevance Health made up ﹤0.01% of Destiny Wealth Partners's portfolio in Q1 2026, its #530 holding.
  • Destiny Wealth Partners first reported a position in Elevance Health in Q4 2020 and has held it in 9 quarters since.
  • Destiny Wealth Partners's Elevance Health position peaked at $69K in Q2 2022.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Destiny Wealth Partners's 13F filing for Q1 2026, filed 11 May 2026.